Comparing the risk of anaphylaxis requiring epinephrine in oral immunotherapy and subcutaneous immunotherapy: A review of recent Canadian real-world literature by Uliana Kovaltchouk, MD, FRCPC, Samira Jeimy, MD, PhD, FRCPC, Lianne Soller, PhD, Kara Robertson, MD, FRCPC, Elissa M. Abrams, MD, FRCPC, Scott B. Cameron, MD, PhD, FRCPC, Harold Kim, MD, FRCPC, Edmond S. Chan, MD, FRCPC

Get full text

Real-world safety and effectiveness analysis of low-dose preschool sesame oral immunotherapy by Gilbert T. Chua, MBBS, Lianne Soller, PhD, Sandeep Kapur, MD, Mary McHenry, MD, Gregory A. Rex, MD, Victoria E. Cook, MSc, MD, Scott B. Cameron, MD, PhD, Edmond S. Chan, MD, Joanne Yeung, MD, Stephanie C. Erdle, MD

Get full text

Risk factors associated with safety of preschool peanut oral immunotherapy by Duva Karunakaran, BSc, Edmond S. Chan, MD, Qian Zhang, Jeffrey N. Bone, Stuart Carr, MD, Sandeep Kapur, MD, Gregory A. Rex, MD, Mary McHenry, MD, Scott B. Cameron, MD, PhD, Victoria E. Cook, MD, Sara Leo, MD, Tiffany Wong, MD, Thomas V. Gerstner, MD, Joanne Yeung, MD, Elissa M. Abrams, MD, Raymond Mak, MD, Stephanie C. Erdle, MD, Lianne Soller, PhD

Get full text